UBS Group
UTRS

UBS Group’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

UBS Group’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,093
Closed -$10.7K – 10231
2023
Q2 		$10.7K Buy
+2,093
New +$10.2K ﹤0.01% 7125
2023
Q1 		– Sell
-2,010
Closed -$8.85K – 11036
2022
Q4 		$8.85K Buy
+2,010
New +$13.3K ﹤0.01% 8719
2022
Q2 		– Sell
-54
Closed -$5K – 11319
2022
Q1 		$5K Sell
54
-182
-77% -$18.5K ﹤0.01% 9208
2021
Q4 		$24K Buy
+236
New +$33.6K ﹤0.01% 7654

Other funds holding UTRS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group's UTRS Position: Q3 2023 in Review

UBS Group sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q3 2023, closing a stake of 2,093 shares — an estimated $10.7K sold.

UBS Group first reported a position in UTRS in Q4 2021 and held it in 4 quarters. The position peaked at $24K in Q4 2021. 13 funds tracked by Wall St. Rank hold UTRS as of Q3 2023.

  • UBS Group reported no remaining Minerva Surgical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 2,093 Minerva Surgical, Inc. Common Stock shares in Q3 2023, an estimated $10.7K.
  • UBS Group first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • UBS Group's Minerva Surgical, Inc. Common Stock position peaked at $24K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.